midostaurin
Showing 1 - 25 of 29
Core Binding Factor Acute Myeloid Leukemia (CBF-AML) Trial in Milano (Midostaurin)
Recruiting
- Core Binding Factor Acute Myeloid Leukemia (CBF-AML)
- Midostaurin
-
Milano, ItalyOspedale Cà Granda - Niguarda S.C: Ematologia
Jan 22, 2022
AML, Adult Trial in Berne (HDM201, Midostaurin)
Recruiting
- AML, Adult
- HDM201
- Midostaurin
-
Berne, SwitzerlandDepartement of Medical Oncology, University Hospital Berne
Jan 27, 2022
FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)
Available
- FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
- midostaurin
- (no location specified)
Feb 1, 2022
Acute Myeloid Leukemia, Adult Trial in Germany (Midostaurin)
Terminated
- Acute Myeloid Leukemia, Adult
- Midostaurin
-
Chemnitz, Germany
- +3 more
Jan 20, 2022
Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)
Recruiting
- Acute Myeloid Leukemia
- CPX-351
- +5 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health of South Florida
Jul 27, 2022
Healthcare Resource Utilization in Adults Diagnosed With Acute
Completed
- Acute Myeloid Leukemia (AML)
- Midostaurin
-
Helsinki, FinlandNovartis Investigative Site
Aug 3, 2022
Hepatic Impairment Trial in Worldwide (Midostaurin)
Completed
- Hepatic Impairment
- Midostaurin
-
San Antonio, Texas
- +6 more
May 8, 2021
Acute Myeloid Leukemia Trial in Canada, United States (Midostaurin, Standard of Care)
Completed
- Acute Myeloid Leukemia
- Midostaurin
- Standard of Care
-
La Jolla, California
- +18 more
Mar 12, 2021
Acute Myeloid Leukemia (AML) Trial in Worldwide (Midostaurin, Midostaurin Placebo, Chemotherapy)
Terminated
- Acute Myeloid Leukemia (AML)
- Midostaurin
- +2 more
-
Chicago, Illinois
- +132 more
Jan 24, 2022
Acute Myeloid Leukemia Trial in Worldwide (Midostaurin)
Completed
- Acute Myeloid Leukemia
- Midostaurin
-
Pleven, Bulgaria
- +85 more
Feb 11, 2022
FLT3-mutated Acute Myeloid Leukemia Trial in Hamilton, Montreal (Midostaurin)
No longer available
- FLT3-mutated Acute Myeloid Leukemia
- Midostaurin
-
Hamilton, Ontario, Canada
- +1 more
Oct 14, 2019
Newly Diagnosed FLT3 Mutated AML Trial in United States (Crenolanib, Midostaurin, Cytarabine)
Recruiting
- Newly Diagnosed FLT3 Mutated AML
- Crenolanib
- +3 more
-
Duarte, California
- +30 more
May 21, 2020
Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, FLT3 Tyrosine Kinase Domain Point
Terminated
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- +4 more
- Decitabine
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jul 17, 2019
Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (Gilteritinib, Midostaurin)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome With Excess Blasts-2
- Gilteritinib
- Midostaurin
-
Adelaide, Australia
- +201 more
Mar 15, 2022
Acute Myeloid Leukemia (AML) Trial in Germany, United States (cytarabine, daunorubicin HCl, midostaurin)
Completed
- Acute Myeloid Leukemia (AML)
- cytarabine
- +2 more
-
Los Angeles, California
- +5 more
Dec 16, 2020
Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD) Trial in
No longer available
- Acute Myeloid Leukemia (AML) With
- FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)
- Midostaurin
-
Phoenix, Arizona
- +43 more
Jul 14, 2020
Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Italy (Cytarabine, Daunorubicin, Midostaurin)
Recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- Cytarabine
- +3 more
-
Bari, Italy
- +19 more
Mar 1, 2022
Adenocarcinoma of the Rectum Trial in Boston (Midostaurin)
Completed
- Adenocarcinoma of the Rectum
- Midostaurin
-
Boston, Massachusetts
- +1 more
Dec 11, 2018
Acute Myeloid Leukemia Trial in Austria, Germany (Midostaurin, Cytarabine, Daunorubicin)
Completed
- Acute Myeloid Leukemia
- Midostaurin
- +2 more
-
Innsbruck, Austria
- +54 more
Jun 3, 2020
Leukemia Trial in Canada, United States (cytarabine, daunorubicin, midostaurin)
Acute Myeloid Leukemia Trial in Gainesville (Midostaurin, Cytarabine)
Withdrawn
- Acute Myeloid Leukemia
- Midostaurin
- Cytarabine
-
Gainesville, FloridaUniversity of Florida
Oct 18, 2018
Systemic Mastocytosis, Aggressive (ASM), Leukemia, Mast Cell, Hematological Non-mast Cell Lineage Disease (AHNMD) Trial in
Completed
- Systemic Mastocytosis, Aggressive (ASM)
- +2 more
- Midostaurin
-
Stanford, California
- +2 more
Sep 19, 2018
Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults, AML (Adult) With 11q23
Terminated
- Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults
- +7 more
- Decitabine
- Midostaurin
-
Stanford, CaliforniaStanford University School of Medicine
Sep 25, 2018